TY - JOUR
T1 - Colectomy rates for ulcerative colitis over time
T2 - Navigating the evidence in the era of precision medicine and individualised treatment
AU - Pellino, Gianluca
AU - Armuzzi, Alessandro
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Nick Dai and colleagues [ [1] ] conducted an up-to-date review of the literature to assess the rates of colectomy for ulcerative colitis (UC) over time, also comparing the pre-biologic vs biologic drug eras. Indeed many clinicians and their patients hoped that biologics would reduce, or even eliminate, the need for surgery,1 and whilst a reduction in colectomy rates occurred, the effect is smaller than expected.
AB - Nick Dai and colleagues [ [1] ] conducted an up-to-date review of the literature to assess the rates of colectomy for ulcerative colitis (UC) over time, also comparing the pre-biologic vs biologic drug eras. Indeed many clinicians and their patients hoped that biologics would reduce, or even eliminate, the need for surgery,1 and whilst a reduction in colectomy rates occurred, the effect is smaller than expected.
UR - http://www.scopus.com/inward/record.url?scp=85141002668&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2022.09.017
DO - 10.1016/j.dld.2022.09.017
M3 - Article
AN - SCOPUS:85141002668
SN - 1590-8658
VL - 55
SP - 1
EP - 2
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
IS - 1
ER -